China says Japanese drug for flu works in treatment of COVID-19
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
THURSDAY, MAY 26, 2022
THURSDAY, MAY 26, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
China says Japanese drug for flu works in treatment of COVID-19

Coronavirus chronicle

TBS Report
18 March, 2020, 07:35 pm
Last modified: 18 March, 2020, 07:39 pm

Related News

  • China seeks Pacific islands policing, security cooperation - document
  • China seeks Pacific islands policing, security cooperation
  • Tightening Covid net, Beijing deals out punishments, stark warnings
  • First direct container ship to China leaves Ctg port
  • US says China and Russia bomber drill shows depth of their alignment

China says Japanese drug for flu works in treatment of COVID-19

Japanese doctors are using the same drug in clinical studies on coronavirus patients with mild to moderate symptoms in hopes that it will prevent the virus from multiplying in patients

TBS Report
18 March, 2020, 07:35 pm
Last modified: 18 March, 2020, 07:39 pm
Photo: Reuters
Photo: Reuters

Chinese medical authorities said a drug used in Japan to treat new strains of influenza apparently has been effective in coronavirus patients. 

The drug, "Favipiravir" also known as "Avigan" has been developed by Fujifilm Toyama Chemical, a subsidy of Fujifilm, reported The Guardian. 

According to Zhang Xinmin, an official at China's science and technology ministry, the drug has shown encouraging outcome after a clinical trial in Wuhan and Shenzhen involving 340 patients, 
"It has a high degree of safety and is clearly effective in treatment," Zhang said. 

Japanese public broadcaster NHK said patients who were given the medicine in Shenzhen turned negative for the virus after a median of four days after becoming positive, compared with a median of 11 days for those who were not treated with the drug. 

X-rays confirmed improvements in lung condition in about 91 percent of the patients who were treated with the drug, compared to the 62 percent of those without the drug.

Fujifilm Toyama Chemical has declined to give any comment on this.

Japanese doctors are using the drug in clinical studies on coronavirus patients with mild to moderate symptoms in hopes that it will prevent the virus from multiplying in patients.

However, a Japanese health ministry source suggested the drug was not as effective in people with more severe symptoms. 

"We have given Avigan to 70 to 80 people, but it doesn't seem to work that well when the virus has already multiplied," the source said to a Japanese newsportal.

In 2016, the Japanese government supplied the drug as emergency aid to counter the Ebola virus outbreak in Guinea. It would need government approval for full-scale use on COVID-19 patients since it was originally intended to treat flu.

Health officials said the drug could be approved as early as May. 

 

World+Biz / Top News

Coronavirus / china / Japan

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Wheat stock at 3-year low and that may not be good for rice
    Wheat stock at 3-year low and that may not be good for rice
  • Photo: Collected
    Bangladesh among top 20 prospective solar farm capacity nations
  • Bangladesh Bank to sit with ABB, BAFEDA Thursday
    Bangladesh Bank to sit with ABB, BAFEDA Thursday

MOST VIEWED

  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules
  • A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
    Pfizer says 3 Covid shots protect children under 5
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing urges millions to keep working from home amid Covid outbreak menace
  • Picture: PTI
    Saudi Arabia bans travel to India, 15 other countries over Covid outbreaks
  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert

Related News

  • China seeks Pacific islands policing, security cooperation - document
  • China seeks Pacific islands policing, security cooperation
  • Tightening Covid net, Beijing deals out punishments, stark warnings
  • First direct container ship to China leaves Ctg port
  • US says China and Russia bomber drill shows depth of their alignment

Features

Psycure has received various awards for their extraordinary contributions to promoting Sustainable Development Goals. Photo: Courtesy

Psycure: Meet the organisation serving the underserved university students (and beyond) with mental healthcare 

13h | Panorama
Underlying problems such as school dropouts need to be addressed first before taking a legal route to stop child labour. Photo: Reuters

‘Child labour in a country like Bangladesh is primarily a development issue, not so much of enforcement’

14h | Panorama
The balcony railings of the Boro Sardar Bari in Sonargaon. Made of cast iron, these railings feature vertical posts with intricate designs on top. Photo: Noor-A-Alam

The evolution of railing and grille designs

1d | Habitat
A Russian army service member fires a howitzer during drills at the Kuzminsky range in the southern Rostov region, Russia January 26, 2022. REUTERS/Sergey Pivovarov/File Photo

3 months of Ukraine war : Miscalculations, resistance and redirected focus

1d | Analysis

More Videos from TBS

Where the people have more weapons than military

Where the people have more weapons than military

2h | Videos
Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

Govt plans to amnesty in the offing to bring back laundered money to meet dollar crises

4h | Videos
Poet Nazrul Islam’s 123rd birth anniversary observed

Poet Nazrul Islam’s 123rd birth anniversary observed

4h | Videos
Soaring commodity prices put pressure on budget

Soaring commodity prices put pressure on budget

9h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

3
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

4
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

5
Illustration: TBS
Banking

Let taka slide

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab